Human Insulatard 40IU/ml Suspension for Injection contains Insulin Isophane (40IU), a long-acting insulin used to improve glycemic control in patients with diabetes mellitus. This intermediate-acting insulin suspension is designed to provide a prolonged duration of action, helping to maintain basal insulin levels and reduce blood glucose fluctuations between meals and overnight. Insulatard is typically administered subcutaneously and may be used alone or in combination with short-acting insulins to achieve optimal glycemic control. The onset of action usually occurs within 1 to 2 hours after injection, with peak effects observed between 4 to 12 hours, and a total duration of action lasting up to 24 hours. Dosage and administration should be individualized based on the patient’s metabolic needs, blood glucose monitoring results, and lifestyle. Careful titration is essential to minimize the risk of hypoglycemia, especially during changes in physical activity, diet, or concurrent illness. Patients should be educated on proper injection techniques, storage conditions, and recognition of hypoglycemia symptoms. Human Insulatard 40IU/ml Suspension for Injection is contraindicated in patients with hypersensitivity to insulin or any excipients. Regular monitoring of blood glucose and periodic assessment of glycemic control are recommended to ensure safe and effective therapy.